Serum levels of soluble Fas in patients with Graves' ophthalmopathy

British Journal of Ophthalmology

Volumn 84, Issue 1, 2000, Pages 103-106

  Ohtsuka, Kenji ^a   Hashimoto, Masato ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; THYROID STIMULATING IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DIPLOPIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; MALE; MUSCLE HYPERTROPHY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD95; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOPHTHALMOS; FACIAL MUSCLES; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 0034063132     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.1.103     Document Type: Article

References (20)

1. Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 1994;92:477-588.
2. Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121284-90.
3. Campbell JC. Immunology of Graves' ophthalmopathy: retrobulbar histology and histochemistry. Acta Endocrinol 1989;121:9-16.
4. Weetman AP, Cohen S, Gatter KC, et al. Immunohistochemical analysis of the retrobulbar tissue in Graves' ophthalmopathy. Clin Exp Immunol 1989;75:222-7.
5. Heufelder AE, Bahn RS. Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993;23:10-17.
6. Drappa J, Vaishnaw AK, Sullivan KE, et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lympho-proliferative disorder associated with autoimmunity. N Engl J Med 1996;335:1643-9.
7. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-62.
8. Bijl M, van Lopik T, Limburg PC, et al. Do elevated levels of serum-soluble Fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? J Autoimmun 1998;11:457-63.
9. Inoue A, Koh CS, Sakai T, et al. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy. J Neuroimmunol 1997;75:141-6.
10. Nozawa K, Kayagaki N, Tokano Y, et al. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum 1997;40:1126-9.
11. Shimaoka Y, Hidaka Y, Okumura M, et al. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases. Thyroid 1998;8:43-7.
12. Heufelder AE, Bahn RS. Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonist. Invest Ophthalmol Vis Sci 1994;35:120-7.
13. Bahn RS, Heufelder AE. Retroocular fibloblasts: important effector cells in Graves' ophthalmopathy. Thyroid 1992;2: 89-94.
14. Tallstedt L, Norgerg R. Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 1988;29:175-84.
15. Ludgate ME, Vassart G. The thyrotropin receptor as a model to illustrate receptor and receptor antibody disease. Baillière's Clin Endocrinol Metab 1995;9:95-113.
16. Morris J, Hay ID, Nelson RE, et al. Clinical utility of thyrotropin receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc 1988;63:707-12.
17. Kazuo K, Fujikado T, Ohmi G, et al. Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmology of euthyroid patients. Br J Ophthalmol 1997;81:1080-3.
18. Bolonkin D, Tate RL, Luber JH, et al. Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem 1975;250:6516-21.
19. Rottela CM, Zonefrati R, Toccanfondi R, et al. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 1986; 62:357-67.
20. Nunery WR. Ophthalmic Graves' disease: a dual theory of pathologenesis. Ophthalmol Clin North Am 1991;4:73-87.